drugset / Trial / NCT04489381

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

NCT04489381

Phase 3 Terminated 214 enrolled Romark Laboratories L.C.
RandomizedParallel-groupTriple-blindTreatment

Summary

Trial to evaluate the efficacy and safety of nitazoxanide in the treatment of colds due to enterovirus/rhinovirus infection

Timeline

Start
2020-08-19
Primary completion
2021-01-28
Completion
2021-02-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitazoxanide Other / unclassified 600 mg Oral